(S (NP (NP (NNP Coronavirus) (NNP Disease) (CD 2019)) (PRN (-LRB- -LRB-) (NP (NNP COVID-19)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (ADJP (RB rapidly) (VBG emerging)) (NN respiratory) (NN disease)) (VP (VBN caused) (PP (IN by) (NP (NP (DT the) (JJ severe) (JJ acute) (NN respiratory) (NN syndrome) (NN coronavirus) (CD 2)) (PRN (-LRB- -LRB-) (NP (NNP SARS-CoV-2)) (-RRB- -RRB-))))))) (. .))
(S (PP (JJ Due) (TO to) (NP (NP (DT the) (JJ rapid) (JJ human-to-human) (NN transmission)) (PP (IN of) (NP (NNP SARS-CoV-2))))) (, ,) (NP (JJ many) (NN healthcare) (NNS systems)) (VP (VBP are) (PP (IN at) (NP (NP (NN risk)) (PP (IN of) (S (VP (VBG exceeding) (NP (PRP$ their) (NN healthcare) (NNS capacities)) (, ,) (PP (PP (IN in) (ADJP (JJ particular))) (PP (IN in) (NP (NP (NNS terms)) (PP (IN of) (NP (NP (NNP SARS-CoV-2) (NNS tests)) (, ,) (NP (NN hospital) (CC and) (JJ intensive) (NN care) (NN unit) (PRN (-LRB- -LRB-) (NNP ICU) (-RRB- -RRB-)) (NNS beds)) (CC and) (NP (JJ mechanical) (NNS ventilators))))))))))))) (. .))
(S (NP (JJ Predictive) (NN algorithms)) (VP (MD could) (ADVP (RB potentially)) (VP (VB ease) (NP (NP (DT the) (NN strain)) (PP (IN on) (NP (NN healthcare) (NNS systems)))) (PP (IN by) (S (VP (VBG identifying) (NP (NP (DT those)) (SBAR (WHNP (WP who)) (S (VP (VBP are) (ADJP (RBS most) (JJ likely) (S (VP (TO to) (VP (VP (VB receive) (NP (DT a) (JJ positive) (JJ SARS-CoV-2) (NN test))) (, ,) (VP (VB be) (VP (VBN hospitalised))) (CC or) (VP (VBN admitted) (PP (TO to) (NP (DT the) (NNP ICU))))))))))))))))) (. .))
(S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP study) (NP (NP (JJ clinical) (JJ predictive) (NNS models)) (SBAR (WHNP (WDT that)) (S (VP (VBP estimate) (, ,) (UCP (VP (VBG using) (NP (NN machine) (NN learning))) (CC and) (PP (VBN based) (PP (IN on) (NP (ADJP (RB routinely) (VBN collected)) (JJ clinical) (NNS data))))) (, ,) (SBAR (WHNP (WDT which) (NNS patients)) (S (VP (VBP are) (ADJP (JJ likely) (S (VP (TO to) (VP (VP (VB receive) (NP (DT a) (JJ positive) (JJ SARS-CoV-2) (NN test))) (, ,) (VP (VB require) (NP (NP (NN hospitalisation)) (CC or) (NP (JJ intensive) (NN care)))))))))))))))) (. .))
(S (S (VP (TO To) (VP (VB evaluate) (NP (NP (DT the) (JJ predictive) (NN performance)) (PP (IN of) (NP (PRP$ our) (NNS models))))))) (, ,) (NP (PRP we)) (VP (VBP perform) (NP (NP (DT a) (JJ retrospective) (NN evaluation)) (PP (IN on) (NP (NP (JJ clinical) (CC and) (NN blood) (NN analysis) (NNS data)) (PP (IN from) (NP (NP (DT a) (NN cohort)) (PP (IN of) (NP (CD 5644) (NNS patients))))))))) (. .))
(S (NP (PRP$ Our) (JJ experimental) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP (PRP$ our) (JJ predictive) (NNS models)) (VP (VBP identify) (NP (NP (NP (PRN (-LRB- -LRB-) (NN i) (-RRB- -RRB-)) (NP (NNS patients))) (SBAR (WHNP (WDT that)) (S (VP (VBP test) (ADVP (JJ positive)) (PP (IN for) (NP (NNP SARS-CoV-2) (DT a) (NN priori))) (PP (IN at) (NP (NP (NP (DT a) (NN sensitivity)) (PP (IN of) (NP (NP (CD 75) (NN %)) (PRN (-LRB- -LRB-) (NP (ADJP (CD 95) (NN %)) (NNP CI)) (: :) (NP (NP (CD 67) (NN %)) (, ,) (NP (CD 81) (NN %))) (-RRB- -RRB-))))) (CC and) (NP (NP (DT a) (NN specificity)) (PP (IN of) (NP (NP (CD 49) (NN %)) (PRN (-LRB- -LRB-) (NP (NP (ADJP (CD 95) (NN %)) (NNP CI)) (: :) (NP (NP (CD 46) (NN %)) (, ,) (NP (CD 51) (NN %)))) (-RRB- -RRB-))))))))))) (, ,) (PRN (PRN (-LRB- -LRB-) (NN ii) (-RRB- -RRB-)) (NP (NP (NNP SARS-CoV-2) (JJ positive) (NNS patients)) (SBAR (WHNP (WDT that)) (S (VP (VBP require) (NP (NP (NN hospitalisation)) (PP (IN with) (NP (NP (CD 0.92) (NNP AUC)) (PRN (-LRB- -LRB-) (NP (NP (ADJP (CD 95) (NN %)) (NNP CI)) (: :) (NP (NP (CD 0.81)) (, ,) (NP (CD 0.98)))) (-RRB- -RRB-)))))))))) (, ,) (CC and) (VP (X (-LRB- -LRB-) (NN iii) (-RRB- -RRB-)) (NP (NP (ADJP (NNP SARS-CoV-2) (JJ positive)) (NNS patients)) (SBAR (WHNP (WDT that)) (S (VP (VBP require) (NP (JJ critical) (NN care)) (PP (IN with) (NP (NP (CD 0.98) (NNP AUC)) (PRN (-LRB- -LRB-) (NP (ADJP (CD 95) (NN %)) (NNP CI)) (: :) (NP (NP (CD 0.95)) (, ,) (NP (CD 1.00))) (-RRB- -RRB-)))))))))))))) (. .))
(S (PP (IN In) (NP (NN addition))) (, ,) (NP (PRP we)) (VP (VBP determine) (SBAR (WHNP (WDT which) (JJ clinical) (NNS features)) (S (VP (VBP are) (ADJP (JJ predictive) (PP (TO to) (NP (WP what) (VB degree)))) (PP (IN for) (NP (NP (DT each)) (PP (IN of) (NP (DT the) (JJ aforementioned) (JJ clinical) (NNS tasks))))))))) (. .))
(S (NP (PRP$ Our) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (JJ predictive) (NNS models)) (VP (VBN trained) (PP (IN on) (NP (ADJP (RB routinely) (VBN collected)) (JJ clinical) (NNS data))))) (VP (MD could) (VP (VB be) (VP (VBN used) (S (VP (TO to) (VP (VP (VB predict) (NP (NP (JJ clinical) (NNS pathways)) (PP (IN for) (NP (NNP COVID-19))))) (, ,) (CC and) (ADVP (RB therefore)) (VP (NN help) (S (VP (VP (VB inform) (NP (NN care))) (CC and) (VP (NN prioritise) (NP (NNS resources))))))))))))))) (. .))
